MENU
GLYC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
GlycoMimetics (GLYC) Ownership - Who owns GlycoMimetics?
GlycoMimetics Inc is a clinical-stage biotechnology company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
9708 Medical Center Drive
Phone
+1 240 243-1201
Employees
35
Web
https://www.glycomimetics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
16.84M
P/E Ratio
N/A
Total Cash
10.72M
Projected Growth
N/A
Total Debt
66.84K
Revenue
N/A
Risk (Beta)
2.25
Dividend Yield
N/A
Total Cash/Share
0.17
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
GLYC
Capitalization
16.8M
P/E Ratio
N/A
Risk (Beta)
2.25
Dividend Yield
N/A
Total Cash
10.7M
Total Cash/Share
0.17
Total Debt
66.8K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
5.31M
P/B Ratio
3.17
Cash Flow
N/A
Earnings
-0.59
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
64.5K
Current Ratio
1.92
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-32.47M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-134.30
Shares Held By Institutions
8.48M
Shares Outstanding - Current
64.5M
Total Liabilities
5.78M
Total Volume MTD
N/A
Value
N/A
Gain YTD
4.819
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of drugs to treat inflammatory diseases and cancer
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
9708 Medical Center Drive
Phone
+1 240 243-1201
Employees
35
Web
https://www.glycomimetics.com